[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370365-105":59,"doc-detail-370365-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prognosis-of-surgically-resected-clinical-stage-1a-non-small-cell-lung-cancers-manifesting-as-a-subsolid-nodule-on-computed-tomography-including-pure-ground-glass-nodules-protocol-objectives-and-methods","Prognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules - Protocol - objectives and methods","","A Cochrane Review protocol for prognosis examines patients with clinical stage 1A non-small cell lung cancer after surgical resection, focusing on CT findings of subsolid nodules, including pure ground glass nodules. The protocol aims to quantify the risk of tumour relapse or recurrence associated with these imaging features. It provides structured review objectives and methodological plans within the Cochrane Database of Systematic Reviews (Issue 3, 2025), detailing how evidence will be gathered and synthesized.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognosis-of-surgically-resected-clinical-stage-1a-non-small-cell-lung-cancers-manifesting-as-a-subsolid-nodule-on-computed-tomography-including-pure-ground-glass-nodules-protocol-objectives-and-methods/370365/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognosis-of-surgically-resected-clinical-stage-1a-non-small-cell-lung-cancers-manifesting-as-a-subsolid-nodule-on-computed-tomography-including-pure-ground-glass-nodules-protocol-objectives-and-methods/370365.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does the protocol aim to study in stage 1A NSCLC?","Question",{"text":113,"@type":114},"The protocol studies prognosis after surgical resection of clinical stage 1A non-small cell lung cancer as shown on CT imaging as subsolid nodules, including pure ground glass nodules.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is prognosis defined in the protocol?",{"text":118,"@type":114},"Prognosis is defined by quantifying the risk of tumour relapse or recurrence after surgery, based on the CT-imaging manifestation.",{"name":120,"@type":111,"acceptedAnswer":121},"What imaging feature is central to the review’s patient grouping?",{"text":122,"@type":114},"The central imaging feature is subsolid nodule appearance on computed tomography, specifically including pure ground glass nodules.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370365,1790805875,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Cochrane  \nLibrary  \nCochrane Database of Systematic Reviews  \nPrognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules ( Protocol)  \nManser R, Malouf R, Marchal C, Pascoe D, Wright GM, Bonney A  \nManser R, Malouf R, Marchal C, Pascoe D, Wright GM, Bonney A.  \nPrognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules ( Protocol) .  \nCochrane Database of Systematic Reviews 2025, Issue 3. Art. No.: CD016091.  \nDOI: 10. 1002/14651858 .CD016091 .  \n[www.cochranelibrary.com](www.cochranelibrary.com)  \nPrognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules (Protocol)  \nCopyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.  \nTA B L E O F C O N T E N T S  \nABSTRACT .................................................................................................................................................................................................. 1  \nBACKGROUND ........................................................................................................................................................................................... 2  \nOBJECT IVES ............................................................................................................................................................................................... 3  \nMETHODS .................................................................................................................................................................................................. 3  \nSUPPLEMENTARY MATERIALS .................................................................................................................................................................. 6  \nADDITIONAL INFORMATION ...................................................................................................................................................................... 6  \nREFERENCES ............................................................................................................................................................................................. 7  \nPrognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules (Protocol)  \nCopyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.  \ni  \n[Prognosis Protocol]  \nPrognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules  \nRenée Manser1,2,3, Reem Malouf4, Corynne Marchal5, Diane Pascoe2,6, Gavin M Wright7, Asha Bonney1,2,8  \n1 Department of Respiratory and Sleep Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia. 2 Department of Medicine ( RMH), The University of Melbourne, Victoria, Australia. 3 Department of Internal Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. 4 NuDield Department of Population Health, Big Data Institute ( BDI), University of Oxford, Oxford, UK. 5 Marie & Louis Pasteur University, Besançon, France. 6 Department of Medical Imaging, The Royal Melbourne Hospital, Parkville, Victoria, Australia.  \n7 University of Melbourne Department of Surgery, St Vincent's Hospital Melbourne, Melbourne, Australia. 8 Department of Respiratory and Sleep Medicine, Eastern Health, Melbourne, Australia  \nContact: Renée Manser, [renee. manser@petermac.org](renee. manser@petermac.org).  \nEditorial group: Cochrane Centra","cbCairrLQGP115bw","https://ap.wps.com/l/cbCairrLQGP115bw","pdf",181345,11,"English","# Abstract\n## Background\n## Objectives\n## Methods\n## Supplementary Materials\n## Additional Information\n## References","[{\"question\":\"What does the protocol aim to study in stage 1A NSCLC?\",\"answer\":\"The protocol studies prognosis after surgical resection of clinical stage 1A non-small cell lung cancer as shown on CT imaging as subsolid nodules, including pure ground glass nodules.\"},{\"question\":\"How is prognosis defined in the protocol?\",\"answer\":\"Prognosis is defined by quantifying the risk of tumour relapse or recurrence after surgery, based on the CT-imaging manifestation.\"},{\"question\":\"What imaging feature is central to the review’s patient grouping?\",\"answer\":\"The central imaging feature is subsolid nodule appearance on computed tomography, specifically including pure ground glass nodules.\"}]","Prognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules - Protocol - objectives and methods | PDF",1790188187,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ed3bd3ab77a3bf9ce3366a3a37b6274.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bee99560130ef67dd9c214501d4d58b.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7fbba6dadb997667fee9a90ffa58413b.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eab81f0544b81c8d3b251336e2d6721c.webp",980,1385]